Advertisement
Eric Schick, Bond's President, stated, "It just makes sense for us topursue the public market at this point in our growth. The equity markets arejust waking up to the potential for companies that are focused onNutraceutical Markets. As people live longer and healthcare costs continue torise at substantial multiples to the cost of living, consumers recognize thatprevention in the form of Nutraceutical Dietary Supplements and Vitamins iscritical. One just has to look down the aisles of their local supermarket ordrug store to see that the amount of real estate being allocated to thesecategories is continuously growing. We believe there is probably a 2-3 yearwindow of opportunity before everyone develops a strategy for pursuingnutraceutical supplements, at which point it could be a little late. Access tofuture mezzanine finance requirements as a public entity, should be easier andreceive higher valuations."
Advertisement
About Bond Laboratories:
Bond Laboratories has brought together a seasoned team of highlysuccessful nutraceutical and pharmaceutical sales and management executives.In the past, they have been instrumental in bringing to market notableproducts in their many forms such as multivitamins and herbal products,including children's chewable vitamins, Warehouse Club multivitamins and otherspecialty supplements. Bond is currently developing proprietary products thataddress these three largest mega-categories by focusing its productdevelopment, marketing, and sales initiatives for unique marketing subgroups.
Safe Harbor
Statements about the Company's future expectations and all otherstatements in this press release other than historical facts, are"forward-looking statements" within the meaning of Section 27A of theSecurities Act of 1933, Section 21E of the Securities Exchange Act of 1934,and as that term is defined in the Private Securities Litigation Reform Act of1995. The Company intends that such forward-looking statements be subject tothe safe harbors created thereby.
The above information contains information relating to the Company that isbased on the beliefs of the Company and/or its management as well asassumptions made by and information currently available to the Company or itsmanagement. When used in this document, the words "anticipate," "estimate,""expect," "intend," "plans," "projects," and similar expressions, as theyrelate to the Company or its management, are intended to identifyforward-looking statements. Such statements reflect the current view of theCompany regarding future events and are subject to certain risks,uncertainties and assumptions, including the risks and uncertainties noted.Should one or more of these risks or uncertainties materialize, or shouldunderlying assumptions prove to be incorrect, actual results may varymaterially from those described herein as anticipated, believed, estimated,expected, intended or projected. In each instance, forward-looking informationshould be considered in light of the accompanying meaningful cautionarystatements herein. Factors that could cause results to differ include, but arenot limited to, successful performance of internal plans, the impact ofcompetitive services and pricing and general economic risks and uncertainties.
SOURCE Bond Laboratories, Inc.
